The incidence of Mycobacterium avium-Mycobacterium intracellulare complex infections has increased in recent years primarily because a significant proportion of acquired immunodeficiency syndrome patients develop disseminated M. avium complex disease. In an effort to develop new tools to study these infections, we have produced eight monoclonal antibodies directed against M. avium. Western blot (immunoblot) specificity analysis and protease sensitivity assays indicate that four of these antibodies recognize M. avium-specific protein epitopes and two react with M. avium complex-specific peptide determinants. These monoclonal antibodies may be useful clinically in the diagnosis of M. avium complex disease and in the laboratory for isolation and characterization of native and recombinant M. avium complex antigens.
The Mycobacterium avium-Mycobacterium intracellulare complex (MAC) bacilli are among the most frequent bacterial isolates from individuals with acquired immunodeficiency syndrome (AIDS) (6, 14, 20) . About 50% of AIDS patients have been reported to be infected with MAC in some regions of the United States (5) . In contrast to nonimmunocompromised hosts where the clinical manifestations are usually pulmonary in nature, MAC bacteria often cause a severe disseminated disease in people afflicted with AIDS. Detection of MAC infections is difficult and is often not determined until autopsy (23) .
Recent hospital-based studies have indicated that at least 10% of AIDS patients may also have tuberculosis. Chemoprophylactic regimens against tuberculosis are recommended for persons who are seropositive for human immunodeficiency virus and have a positive tuberculin test (18) . Because of antigenic cross-reactivity between mycobacterial species, positive tuberculin tests are not always indicative of tuberculosis infection and may result from exposure to nontuberculous mycobacteria (2, 3, 4) . The differentiation between MAC and Mycobacterium tuberculosis infections is of clinical importance because M. tuberculosis can be treated with standard antituberculosis drugs, while MAC strains are often resistant to these and other antibiotics. Preventive treatment of human immunodeficiency virusseropositive persons suspected of being infected with MAC may abort the severe clinical complications of MAC-disseminated disease if the patient develops AIDS.
We report here the production and characterization of eight anti-M. avium monoclonal antibodies (MAbs) which react with MAC protein-associated epitopes. Our results suggest that four of these MAbs recognize M. avium epitopes and two are specific for MAC epitopes. These antibodies may be especially useful for the diagnosis of MAC infections, for purification and characterization of native mycobacterial antigens, and for screening MAC Xgtll expression libraries (15) . Immunoreactive peptides derived from MAb-reactive recombinant mycobacterial proteins being expressed in these gene libraries will be evaluated as specific skin test and serodiagnostic reagents and as components of acellular vaccines. (Fig. 1A through D) . Anti further studies with a larger number of mycobacterial sonicates will be required to ascertain absolute specificity. To evaluate the reactivity of these MAbs against different M. avium isolates, the antibodies were blotted against sonicates generated from 10 M. avium isolates. Nine of the M. avium isolates were derived from patients with AIDS. These included serovar 3b, 4, 4b, 8, and 20a strains and an untypeable strain. The remaining M. avium isolate was a Weybridge strain culture. The species-specific monoclonal antibodies, 3954 B12, 3989 Cl, 4055 E6, and 4064 E6, strongly react with all of the M. avium strains tested (data not shown).
Two of the M. avium MAbs are apparently specific for the MAC (Fig. 2) . Antibody 3917 Fl binds a 34-kDa protein only in M. avium and M. intracellulare sonicates, while 4004 F3 reacts with a 20-kDa MAC antigen. Both of these MAbs also react strongly with the 10 other M. avium sonicates described above. In contrast to the specific reactivities of the MAbs described above, 4045 H12 (Fig. 4) (7, 13, 19, 22) . We have recently described the isolation of four Xgtll clones which express recombinant M. intracellulare proteins by using anti-M. intracellulare MAbs (16) . We are confident that the anti-M. avium MAbs characterized in this report will also be useful for screening mycobacterial expression libraries. A recombinant bacteriophage isolated from a M. avium Agtll library that expresses an antigen recognized by the antibody 3954 B12 has already been identified (D. Rouse and S. Morris, unpublished results). Evaluation of these recombinant MAC proteins will increase our knowledge of the basic biology of MAC antigens. Furthermore, peptides derived from these recombinant mycobacterial proteins have potential clinical utility in a specific skin test or as serodiagnostic reagents for M. avium disease and as acellular vaccine components.
